CAD 0.35
(6.15%)
Year | Net Income | Net Income Growth |
---|---|---|
2022 | -5.72 Million CAD | -42.22% |
2021 | -4.02 Million CAD | -2683.94% |
2020 | -144.65 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q3 | 67.84 Thousand CAD | 262.51% |
2023 Q2 | 18.71 Thousand CAD | 107.64% |
2023 Q1 | -244.86 Thousand CAD | 66.05% |
2022 Q4 | -721.2 Thousand CAD | 27.18% |
2022 Q3 | -990.35 Thousand CAD | 69.28% |
2022 Q2 | -3.22 Million CAD | -306.85% |
2022 Q1 | -792.29 Thousand CAD | -42.55% |
2022 FY | -5.72 Million CAD | -42.22% |
2021 Q1 | -38.78 Thousand CAD | -13.37% |
2021 FY | -4.02 Million CAD | -2683.94% |
2021 Q2 | 160.73 Thousand CAD | 514.48% |
2021 Q4 | -555.78 Thousand CAD | 83.13% |
2021 Q3 | -3.29 Million CAD | -2150.02% |
2020 FY | -144.65 Thousand CAD | 0.0% |
2020 Q4 | -34.2 Thousand CAD | 0.0% |
2020 Q2 | -34.91 Thousand CAD | 0.0% |
2019 Q4 | -40.36 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -6.78 Million CAD | 15.542% |
Asep Medical Holdings Inc | -8.22 Million CAD | 30.387% |
BetterLife Pharma Inc. | -2.88 Million CAD | -98.242% |
BioVaxys Technology Corp. | -7.68 Million CAD | 25.497% |
ChitogenX Inc. | -1.55 Million CAD | -268.551% |
Rapid Dose Therapeutics Corp. | -4.3 Million CAD | -32.992% |
Defence Therapeutics Inc. | -13.19 Million CAD | 56.589% |
Entheon Biomedical Corp. | -300 Thousand CAD | -1809.087% |
Gemina Laboratories Ltd. | -5.21 Million CAD | -9.786% |
Glow Lifetech Corp. | -1.64 Million CAD | -248.033% |
Lexston Life Sciences Corp. | -867.71 Thousand CAD | -560.043% |
Pharmala Biotech Holdings Inc. | -779.81 Thousand CAD | -634.443% |
Doseology Sciences Inc. | -339.84 Thousand CAD | -1585.248% |
MYND Life Sciences Inc. | -1.51 Million CAD | -277.326% |
Nova Mentis Life Science Corp. | -1.22 Million CAD | -367.754% |
PharmaTher Holdings Ltd. | -3.11 Million CAD | -83.841% |
PreveCeutical Medical Inc. | -1.27 Million CAD | -349.385% |